Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts.
Marfella R, D'Onofrio N, Trotta MC, Sardu C, Scisciola L, Amarelli C, Balestrieri ML, Grimaldi V, Mansueto G, Esposito S, D'Amico M, Golino P, Signoriello G, De Feo M, Maiello C, Napoli C, Paolisso G.
Marfella R, et al. Among authors: signoriello g.
Metabolism. 2022 Feb;127:154936. doi: 10.1016/j.metabol.2021.154936. Epub 2021 Nov 18.
Metabolism. 2022.
PMID: 34801581
Free article.
Clinical Trial.